Canada Life
AXSM icon

Canada Life’s Axsome Therapeutics AXSM Stock Holding History

Canada Life’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$680K Hold
4,007
– – ﹤0.01% 1441
2025
Q4 		$732K Sell
4,007
-4,984
-55% -$696K ﹤0.01% 1443
2025
Q3 		$1.06M Buy
8,991
+1,586
+21% +$179K ﹤0.01% 1428
2025
Q2 		$775K Buy
7,405
+4,293
+138% +$455K ﹤0.01% 1500
2025
Q1 		$364K Hold
3,112
– – ﹤0.01% 1661
2024
Q4 		$263K Sell
3,112
-239
-7% -$22K ﹤0.01% 1726
2024
Q3 		$301K Sell
3,351
-4,248
-56% -$371K ﹤0.01% 1757
2024
Q2 		$611K Buy
7,599
+229
+3% +$17K ﹤0.01% 1632
2024
Q1 		$588K Buy
7,370
+4,258
+137% +$357K ﹤0.01% 1652
2023
Q4 		$246K Hold
3,112
– – ﹤0.01% 1807
2023
Q3 		$217K Buy
3,112
+1,700
+120% +$127K ﹤0.01% 1842
2023
Q2 		$102K Sell
1,412
-129
-8% -$9.52K ﹤0.01% 1924
2023
Q1 		$95K Hold
1,541
– – ﹤0.01% 1985
2022
Q4 		$119K Hold
1,541
– – ﹤0.01% 1959
2022
Q3 		$69K Hold
1,541
– – ﹤0.01% 2050
2022
Q2 		$59K Hold
1,541
– – ﹤0.01% 2023
2022
Q1 		$68K Hold
1,541
– – ﹤0.01% 2089
2021
Q4 		$58K Hold
1,541
– – ﹤0.01% 2134
2021
Q3 		$51K Hold
1,541
– – ﹤0.01% 2229
2021
Q2 		$104K Sell
1,541
-514
-25% -$30.8K ﹤0.01% 2081
2021
Q1 		$115K Hold
2,055
– – ﹤0.01% 2067
2020
Q4 		$167K Hold
2,055
– – ﹤0.01% 2008
2020
Q3 		$146K Hold
2,055
– – ﹤0.01% 1960
2020
Q2 		$168K Buy
2,055
+445
+28% +$34.3K ﹤0.01% 1946
2020
Q1 		$96K Hold
1,610
– – ﹤0.01% 1985
2019
Q4 		$165K Buy
+1,610
New +$65K ﹤0.01% 1967
2019
Q3 		– Sell
-3,035
Closed -$78K – 1227
2019
Q2 		$78K Buy
+3,035
New +$60.8K ﹤0.01% 2302

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's AXSM Position: Q1 2026 in Review

Canada Life held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 4,007 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

Canada Life first reported a position in AXSM in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.06M in Q3 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Canada Life held 4,007 shares of Axsome Therapeutics worth $680K as of Q1 2026.
  • Canada Life left its Axsome Therapeutics share count unchanged in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1441 holding.
  • Canada Life first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 27 quarters since.
  • Canada Life's Axsome Therapeutics position peaked at $1.06M in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.